Everlab Secures $65 Million in Latest Pre-Series A Funding Round

Everlab secured $65 million in its latest Pre-Series A, adding another data point to the Healthcare & Life Sciences funding market.

Everlab Raises $65 million in Funding

Everlab Raises AU$65M Series A. Everlab raises AU$65M in Series A funding led by Airtree Ventures to scale its AI-powered preventative healthcare platform globally.

Investors Behind the Funding

The round was backed by Airtree Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Everlab operates in Healthcare & Life Sciences. Everlab's Pre-Series A round shows investors are still backing digital health platforms with real scale narratives. At $65M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Expand its AI-driven preventative healthcare platform globally.

Looking Ahead

Everlab Raises AU$65M Series A

Source reference: original announcement/article.